Palvella Therapeutics (PVLA): Chief Operating Officer Goin Kathleen sold $537,307 worth of shares (4,313 units at $124.58) as part of a pre-agreed trading plan (SEC Form 4)
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for PVLA
Across the 30 sessions after earlier PVLA headlines, the stock closed higher 18 times and lower 12 times, with a median move of 3.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PVLA | SPY |
|---|---|---|---|
| Oct 16, 2026 | William Blair initiated coverage on Palvella Therapeutics | -5.5% | -1.1% |
| Oct 15, 2026 | Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference | +3.9% | +0.3% |
| Oct 13, 2026 | Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference | -4.4% | -0.0% |
| Oct 12, 2026 | Palvella Therapeutics Announces Three Poster Presentations Highlighting New Data in Microcystic Lymphatic Malformations and DSAP at Fall Clinical Dermatology 2026 | -3.2% | -0.1% |
| Sep 28, 2026 | U.S. Food and Drug Administration Awards Additional Funding for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations | +1.2% | -0.7% |
| Sep 21, 2026 | Chardan Capital Markets resumed coverage on Palvella Therapeutics with a new price target | +1.9% | +1.6% |
Earlier insider filings at PVLA
- Oct 14, 2026Director Jenkins George M sold $3,579,476 worth of shares (27,500 units at $130.16) as part of a pre-agreed trading plan (SEC Form 4)
- Sep 18, 2026Chief Operating Officer Goin Kathleen exercised 4,302 shares at a strike of $8.11 and sold $654,923 worth of shares (4,302 units at $152.24) as part of a pre-agreed trading plan (SEC Form 4)
- Sep 16, 2026Director Jenkins George M sold $4,167,146 worth of shares (27,500 units at $151.53) as part of a pre-agreed trading plan, decreasing direct ownership by 15% to 160,116 units (SEC Form 4)
- Sep 4, 2026Director Kiritsy Christopher P sold $49,141 worth of shares (313 units at $157.00) and exercised 313 shares at a strike of $127.20 (SEC Form 4)
- Aug 20, 2026Chief Operating Officer Goin Kathleen exercised 4,302 shares at a strike of $8.11 and sold $654,791 worth of shares (4,302 units at $152.21) as part of a pre-agreed trading plan (SEC Form 4)
Quantisnow market dataNASDAQ
PVLA
Palvella Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for PVLA
Full PVLA profile on Quantisnow Follow PVLA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time